'Abuse potential' diaporamas de présentation

A QUESTION OF VALUES Substance misuse THE ELDERLY

Professor Ilana Crome Keele University 21 March 2013 . A QUESTION OF VALUES Substance misuse THE ELDERLY . Thanks to colleagues and friends. Prof Peter Crome Dr Tony Rao Dr Martin Frisher Dr Roger Bloor Dr Alex Baldacchino Drs Ishbel Moy & Harvinder Sidhu, our future!

789 views • 69 slides

Epidemiological Update on the Prescription Drug Abuse Problem

766 views • 64 slides

Alcohol and Co-Occurring Psychiatric Disorders

Alcohol and Co-Occurring Psychiatric Disorders. Kathleen Brady, M.D., Ph.D. Medical University of South Carolina. Overview. Prevalence Relationship between psychiatric and alcohol use disorders Differential Diagnosis Course of Illness Treatment. Specific Disorders of Focus.

832 views • 56 slides

Greg Connell, Ph.D. Office: 3-126 BSBE; Phone: 624-3132 Email:gconnell@lentid.umn

PRESCRIPTION DRUG ABUSE. Pharmacology: Drugs and Disease - Feb. 25, 2004. Greg Connell, Ph.D. Office: 3-126 BSBE; Phone: 624-3132 Email:gconnell@lenti.med.umn.edu. Drug Abuse. 1. Definitions. 2. Biological basis of drug abuse. 3. Prescription drugs with abuse potential.

502 views • 41 slides

Fixed Dose Combinations & Rational Pharmacotherapeutics

Fixed Dose Combinations & Rational Pharmacotherapeutics. DR VIJAY THAWANI vijaythawani@rediffmail.com vijaythawani.blogspot.com http://groups.yahoo.com/group/ netrum. Background. > 70,000 formulations From about 750 API Domestic retail market = 70,000 crores p.a.

501 views • 33 slides

Narcotics (Opioids) Chapter 9

Narcotics (Opioids) Chapter 9. The term narcotic currently refers to naturally occurring substances derived from the opium poppy and their synthetic substitutes. These drugs are referred to as the opioid (or opiate) narcotics because of their association with opium. What Are Narcotics?.

277 views • 27 slides

PHM 456H Introduction to Pediatric Pharmacy Practice 2004 Drug Related Issues in Pediatric Psychiatry

PHM 456H Introduction to Pediatric Pharmacy Practice 2004 Drug Related Issues in Pediatric Psychiatry. Claire De Souza BSc MD FRCP(C) November 4 th 2004. Audience Survey: . Experience with pediatric psychiatry: medications? patients?. Learning Objectives.

476 views • 25 slides

Richard B. Francoeur, Ph.D. Associate Professor of Social Work Adelphi University

421 views • 25 slides

Human Abuse Potential Studies: Subject Selection and Study Design

Human Abuse Potential Studies: Subject Selection and Study Design. Roland R. Griffiths Johns Hopkins University School of Medicine. Science of Abuse Liability Assessment: Public Workshop Sponsored by NIDA, FDA, & CPDD

502 views • 24 slides

CH. 24 Illegal Drugs

CH. 24 Illegal Drugs. Health Ed. Drugs. Chemically altering substance Drugs are grouped according to their affects on the body. What is Illegal?. Comprehensive Drug Abuse Prevention and Control Act of 1970- This act divided drugs into 5 categories based on abuse potential and medical use.

423 views • 22 slides

Chapter 7 - Drugs

449 views • 20 slides

Opiates & Opioid Narcotics

Opiates & Opioid Narcotics. http://www.aurorawdc.com/ci/oxycontin.jpg. http://www.pharmainfo.net/files/u4145/Morphine.jpg. Definitions. Opiates: drugs naturally found in opium (morphine and codeine) Opioids: exogenous substances, natural or synthetic, with properties similar to opium

351 views • 18 slides

Drugs of Abuse

Drugs of Abuse. Overview. Many Ways to Categorize Drugs. NIDA (National Institute of Drug Abuse) uses this list. Acid/LSD Alcohol Club Drugs Cocaine Ecstasy/MDMA Heroin Inhalants Marijuana Methamphetamine PCP/Phencyclidine Prescription Medications Smoking/Nicotine

422 views • 17 slides

Mark Ammann, Pharm.D. Chair, CCALC President, Catalyst Regulatory Services, LLC

Science of Abuse Liability Assessment November 10, 2011. Perspective of Cross Company Abuse Liability Consortium (CCALC) - Applications and Future Research Needs. Mark Ammann, Pharm.D. Chair, CCALC President, Catalyst Regulatory Services, LLC. Disclosure.

298 views • 14 slides

Focusing on Abuse, Not Use, In Drug Education

Focusing on Abuse, Not Use, In Drug Education. Thomas Nicholson, PhD, MPH Professor of Public Health Western Kentucky University David F. Duncan, DrPH President Duncan & Associates John White, PhD Professor of Public Health Western Kentucky University Fred Stickle, PhD

285 views • 13 slides

Medical Marijuana HB4856

Medical Marijuana HB4856. Briana Adams Kevin Payton Angela Allen. Marijuana Plants / Cannabis. HISTORY.

226 views • 11 slides

Chapter 65

Chapter 65. Androgens. Androgens. Produced by the testes, ovaries, and adrenal cortex Major endogenous androgen is testosterone Noted most for their ability to promote expression of male sex characteristics Significant physiologic and pharmacologic effects unrelated to sex. Androgens.

227 views • 11 slides

Gabapentinoid Abuse: An Alarming Trend

Gabapentinoid Abuse: An Alarming Trend. Kirk Evoy , PharmD PGY2 Ambulatory Care Resident St. Joseph Regional Medical Center The speaker has no actual or potential conflicts of interest to disclose. The Current Issue. Gabapentin (GBP) and pregabalin (PRG) abuse on the rise

335 views • 11 slides

Mission of the Diversion Control Program

Drug Enforcement Administration Margaret A. Brophy Diversion Program Manager New York Field Division (212)337-1193. Mission of the Diversion Control Program.

121 views • 10 slides

METHOD, Continued Procedures

Child Abuse Potential and Maternal Perceptions of Infant Temperament Melissa D. Swartzmiller, Katherine L. Guyon, and Alissa C. Huth-Bocks Eastern Michigan University. INTRODUCTION. RESULTS. METHOD, Continued Procedures

123 views • 1 slides